Shiseido Future Solution Lx Total Protective

Product NDC: 58411-102
11-digit product format: 584110102
Labeler code: 58411
Product ID: 58411-102_b4b702b2-f766-4e87-8c1f-a9e5ebff6ee5
Type: HUMAN OTC DRUG
Nonproprietary name: AVOBENZONE, OCTINOXATE, and OCTOCRYLENE
Dosage form: CREAM
Route: TOPICAL
Labeler: SHISEIDO AMERICAS CORPORATION
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2013-08-01
Marketing end: 0000-00-00
Substance: AVOBENZONE; OCTINOXATE; OCTOCRYLENE
Active strength: 1255 mg/50.2g; mg/50.2g; mg/50.2g
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	58411-102		D	Discontinued by firm		2026-10-15
excluded package	package	58411-102	58411-102-50	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 34 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58411-102-50	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58411-102-50	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58411-102-50	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58411-102-50	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58411-102-50	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58411-102-50	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58411-102-50	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58411-102-50	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58411-102-50	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58411-102-50	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58411-102-50	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58411-102-50	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58411-102-50	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58411-102-50	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58411-102-50	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58411-102-50	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	58411-102-50	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58411-102-50	2023-11-30	C162847	48780-1	ba0f9c33-168f-a910-e053-dadaa90a0b85	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE
58411-102-50	2021-01-29	C162847	48780-1	ba0f9c33-168f-a910-e053-dadaa90a0b85	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
AVOBENZONE	ACTIVE INGREDIENT	G63QQF2NOX	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
AVOBENZONE	ACTIVE MOIETY	G63QQF2NOX	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
.ALPHA.-TOCOPHEROL	INACTIVE INGREDIENT	H4N855PNZ1	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
AVERRHOA CARAMBOLA LEAF	INACTIVE INGREDIENT	HB7UP0QK1T	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
DIPHENYLSILOXY PHENYL TRIMETHICONE	INACTIVE INGREDIENT	I445L28B12	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
DIPROPYLENE GLYCOL	INACTIVE INGREDIENT	E107L85C40	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
DISTEARYLDIMONIUM CHLORIDE	INACTIVE INGREDIENT	OM9573ZX3X	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
DOCOSANOL	INACTIVE INGREDIENT	9G1OE216XY	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
ERYTHRITOL	INACTIVE INGREDIENT	RA96B954X6	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
GREEN TEA LEAF	INACTIVE INGREDIENT	W2ZU1RY8B0	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
HYDROGENATED POLYDECENE (550 MW)	INACTIVE INGREDIENT	U333RI6EB7	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
JOJOBA OIL	INACTIVE INGREDIENT	724GKU717M	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
ONONIS SPINOSA ROOT	INACTIVE INGREDIENT	FD2FMC53M1	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
PIPERIDINEPROPIONIC ACID	INACTIVE INGREDIENT	6L69A7VPHO	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
POLYETHYLENE GLYCOL 1000	INACTIVE INGREDIENT	U076Q6Q621	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
SODIUM METHYL STEAROYL TAURATE	INACTIVE INGREDIENT	JFM219LJ55	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
SODIUM POLYMETAPHOSPHATE	INACTIVE INGREDIENT	P1BM4ZH95L	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1
ZANTHOXYLUM PIPERITUM FRUIT RIND	INACTIVE INGREDIENT	728JDI7G4M	SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE (AVOBENZONE, OCTINOXATE, AND OCTOCRYLENE) CREAM [SHISEIDO AMERICAS CORPORATION]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
G63QQF2NOX	AVOBENZONE	70356-09-1	AVOBENZONE
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
SHISEIDO FUTURE SOLUTION LX TOTAL PROTECTIVE	SHISEIDO AMERICAS CORPORATION \| SHISEIDO AMERICA INC.	2019-12-20	HUMAN OTC DRUG LABEL	2

Shiseido Future Solution Lx Total Protective

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#